Galectin Therapeutics Inc (GALT)
3.45
-0.05
(-1.43%)
USD |
NASDAQ |
Apr 26, 16:00
3.46
+0.01
(+0.29%)
After-Hours: 20:00
Galectin Therapeutics Max Drawdown (5Y): 88.76% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 88.76% |
| February 29, 2024 | 88.76% |
| January 31, 2024 | 88.76% |
| December 31, 2023 | 88.76% |
| November 30, 2023 | 88.76% |
| October 31, 2023 | 88.76% |
| September 30, 2023 | 88.76% |
| August 31, 2023 | 88.76% |
| July 31, 2023 | 88.76% |
| June 30, 2023 | 88.76% |
| May 31, 2023 | 88.76% |
| April 30, 2023 | 88.76% |
| March 31, 2023 | 88.76% |
| February 28, 2023 | 88.76% |
| January 31, 2023 | 88.76% |
| December 31, 2022 | 88.76% |
| November 30, 2022 | 87.55% |
| October 31, 2022 | 87.01% |
| September 30, 2022 | 91.58% |
| August 31, 2022 | 91.58% |
| July 31, 2022 | 91.58% |
| June 30, 2022 | 91.58% |
| May 31, 2022 | 91.58% |
| April 30, 2022 | 91.58% |
| March 31, 2022 | 91.58% |
| Date | Value |
|---|---|
| February 28, 2022 | 91.58% |
| January 31, 2022 | 91.58% |
| December 31, 2021 | 91.58% |
| November 30, 2021 | 94.48% |
| October 31, 2021 | 94.81% |
| September 30, 2021 | 95.25% |
| August 31, 2021 | 97.21% |
| July 31, 2021 | 97.21% |
| June 30, 2021 | 97.21% |
| May 31, 2021 | 97.21% |
| April 30, 2021 | 97.21% |
| March 31, 2021 | 97.21% |
| February 28, 2021 | 97.21% |
| January 31, 2021 | 97.21% |
| December 31, 2020 | 97.21% |
| November 30, 2020 | 97.21% |
| October 31, 2020 | 97.21% |
| September 30, 2020 | 97.21% |
| August 31, 2020 | 97.21% |
| July 31, 2020 | 97.21% |
| June 30, 2020 | 97.21% |
| May 31, 2020 | 97.21% |
| April 30, 2020 | 97.21% |
| March 31, 2020 | 97.21% |
| February 29, 2020 | 97.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
87.01%
Minimum
Oct 2022
97.21%
Maximum
Apr 2019
93.57%
Average
95.03%
Median
Max Drawdown (5Y) Benchmarks
| Madrigal Pharmaceuticals Inc | 82.20% |
| Viking Therapeutics Inc | 89.26% |
| 89bio Inc | -- |
| Terns Pharmaceuticals Inc | -- |
| Enanta Pharmaceuticals Inc | 92.26% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -27.12 |
| Beta (5Y) | 0.8446 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.68% |
| Historical Sharpe Ratio (5Y) | -0.2185 |
| Historical Sortino (5Y) | -0.6211 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.73% |